Byrne et al. demonstrated that elevated plasma NfL levels are associated with neurodegeneration and regional brain atrophy, particularly in the caudate nucleus and putamen, supporting NfL’s potential as a biomarker for disease progression in HD [79]. This evidence concerns the gene NEFL and Brain atrophy.